Shane Skinner has invested in biotech companies for almost 20 years and placed over $2.6 million in biotech stock trades in 2013. He has held various financial leadership positions over the past 17 years throughout the United States and Europe including Chief Financial Officer. Shane graduated from Pepperdine University with an MBA, York College with a bachelor's degree in accounting, and is a licensed CPA. He was a collegiate soccer and rugby player and still plays in recreational leagues in Seattle. He has a wife, son, and one on the way!
Full time sales rep with two kids. Used to just google stocks for info, but came across SA in December 2013 and was hooked. Would love to do this full time one day...fascinated with finding those diamonds in the rough, specifically biotechs.
Spent a month learning by reading SA articles/comments and googling terminology. There are a lot of smart folks here, so I have sifted thru the BS and made my first long term investment in $PVCT early in January 2014. Looking forward to a fun ride with more to come!
Retired from engineering/management since 1997. Largely biotech, but some other stocks and real estate investor for over 25 years. Enjoy skiing, sailing, sports. I enjoy the role of Devil's Advocate, so some of what I say may be to provoke discussion, and may not reflect my actual opinion.
I'm currently undergoing treatment for Acute Lymphoblastic Leukemia. I had planed to be skiing now, but sometimes life gets in the way of your plans. While I'm confident of achieving remission, I intend to be very critical of the FDA for the way drug testing is done. I'm strongly in favor of streamlining the clinical trial process, especially when related to drugs for potentially terminal diseases. I am scheduled for stem cell transplantation late this month (4/15).
Casual Investor // Former Employer, BMO Bank of Montreal - Asset Based Lending Evaluate actual performance of assets in relation to projected results and assist in the strategic review of current business plan. Work with team members in the coordination of and due diligence for various capital transactions, including acquisitions, dispositions and financings. Expansion ( Biotech, Retail, Energy) Turnaround Acquisition or Buy-out // Current Employer, Kuehne + Nagel, (Logistics) Logistics Cost Optimization Smart mix of process, analytics and technology. B.A. Economics and Finance (U of O)
-Molecular Biology and Neuroscience major from Princeton 2012
-Emory University MD Candidate 2018
-Investing in Biopharma since 2010
-Primarily use past trends to support bull call spread positions. These are used for downside protection against volatile positions will gaining from the high premium
Donate to my May 2014 Swim for MS campaign. 30 miles in 30 days to raise awareness of the average age of a MS diagnosis.
Investor focused primarily on the Biotech Industry. I look for undervalued companies with strong management, unmet disease state and quality pipeline. I have worked in the biotech industry for many years and have a strong background in science and statistics.